Chimeric Rhodopsin | Clinical Trials Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

1,746 results for “Chimeric Rhodopsin”

Need more precision?

Filter by phase, recruitment status, country, sponsor, age, and study type.

Refine trial search

Oral Hydroxychloroquine (HCQ) for Retinitis Pigmentosa Caused by P23H- Rhodopsin (RHO)

8 participants · First posted Oct 9, 2019

Tetravalent Chimeric Dengue Vaccine Trial

72 participants · First posted Apr 26, 2010

Mixed Chimeric Transplantation for Primary Amyloidosis

First posted Sep 16, 2005

Chimeric Antigen Receptor Treatment Targeting CD70 (SEVENTY)

78 participants · First posted Apr 3, 2024

Active, not recruiting

Duvelisib Following Chimeric Antigen Receptor T-Cell Therapy

42 participants · First posted Sep 14, 2021

Chimeric Antigen Receptor T Cells Targeting Glypican-3

9 participants · First posted Mar 21, 2019

Cellular Immunotherapy for Relapsed or Refractory Lymphoma Data Collection

1,000 participants · First posted Aug 7, 2024

Not yet recruiting

Safety and Immunogenicity of Chimeric Hemagglutinin mRNA Vaccine Candidates

60 participants · First posted Jul 14, 2026

Active, not recruiting

Multi-modular Chimeric Antigen Receptor Targeting GD2 in Neuroblastoma

12 participants · First posted Aug 14, 2023

AML Cell Immunotherapy Using Chimeric Antigen Receptor T-cells

86 participants · First posted Nov 19, 2019

Page 1 of 106